Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia.
Ozempic
Posted inNPR
Brain scientists are seeking weight-loss drugs without the nausea
Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects. Brain scientists are looking for ways to solve this problem.
Posted inNPR
White House strikes deals for lower prices on obesity drugs
Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some limitations.
Posted inNPR
Searching ‘weight’ can bring up Ozempic in results. It’s a drug advertising loophole
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there’s a lot more wiggle room when companies pay to sponsor online search results.
Posted inNPR
Advice for trying GLP-1 drugs for weight loss from a doctor who’s been there
Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with pitfalls. Here’s his tips for how to use them successfully.
Posted inNPR
Medicare negotiations underway to lower prices for next batch of drugs
In the shadow of President Trump’s efforts to lower drug prices, the Medicare drug price negotiation process that began in the Biden administration continues.
Posted inHealth, Local
Health care costs in Rhode Island continue to rise, report finds
The popularity of expensive weight-loss medications and other prescription drugs along with higher hospital costs are driving up health care spending in Rhode Island – more evidence, state regulators said, of why insurers need to reduce red tape for doctors and increase spending on primary care, according to a report released Monday. The amount of […]
Posted inNPR
I quit Ozempic and embraced feeling healthy over striving for thinness
Taking the drug made one writer feel so sick she quit and focused on healthy habits instead of her body size. Turns out, 65% of people using GLP-1 drugs for weight loss quit within a year.
Posted inNPR
Drugmakers and pharmacists battle over who gets to make obesity drugs
The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from making cheaper copies. They argue they can keep up with demand on their own.
Posted inNPR
Ozempic shows promise for treating alcohol and drug abuse, study finds
The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down substance use cravings too.
